Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding

PHASE2CompletedINTERVENTIONAL

Enrollment

370

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions

Peptic Ulcer

Interventions

DRUG

Somatostatin UCB (drug)

Trial Locations (22)

Brussels

Leuven

Liège

Angers

Bobigny

Créteil

Paris

Villejuif

Athens

Crete-Hellas

Budapest

Debrecen

Győr

Kaposvár

Vác

Bydgoszcz

Krakow

Pruszków

Warsaw

Alicante

Barcelona

Madrid